USPTO serial 79292517
FF FIBROFIND
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 30, 2021
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FF FIBROFIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gateshead Tyne & Wear NE8 1LU, GB
Gateshead, Tyne & Wear NE8 1LU, GB
Gateshead, Tyne & Wear NE8 1LU, GB
Gateshead, Tyne & Wear NE8 1LU, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ali R. Latifi
Ali R. Latifi Tucker & Latifi, LLP160 East 84th StreeSuite 5ENew York, NY 10028Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the treatment of fibrotic diseases; pharmaceutical preparations for the treatment of fibrotic diseases | ACTIVE | — |
| 009 | Bioreactors for research use, specifically for cell culturing; bioreactors for laboratory use; bioreactor rockers for laboratory use; parts for all the aforesaid | ACTIVE | — |
| 010 | Medical testing instruments, namely, blood test tube rockers and test tube rockers for use in medical testing of body fluid samples | ACTIVE | — |
| 042 | Biological research; scientific research; medical research services; research and development of vaccines and medicines; research on the subject of pharmaceuticals; product research and development services; testing of pharmaceuticals; laboratory research services relating to the testing of pharmaceuticals; pharmaceutical and drug development services; conducting clinical trials for others; computer modelling for drug and pharmaceutical research; advisory and information services relating to all the aforesaid | ACTIVE | — |
| 044 | Medical testing for diagnostic and treatment purposes; advisory, consultancy and information services relating to all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fibrofind Ltd
- Other trademarks owned by Fibrofind IP Limited
- Other trademarks owned by Fibrofind IP Limited
- Other trademarks owned by Fibrofind IP Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named FF FIBROFIND
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 20, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 19, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 28, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 16, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 16, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 16, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 2, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 30, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 29, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |